Sept 8 (Reuters) – Eli Lilly’s (LLY.N) diabetes drug Mounjaro has gained the backing of Britain’s healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly… [read more]
Lilly’s diabetes drug gains backing of UK watchdog -Bloomberg News – Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FAQTJ67KUNKL3H6NZ4DIJMOMOI.jpg "Lilly’s diabetes drug gains backing of UK watchdog -Bloomberg News – Reuters")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/F37FNAVHEFPHBNFBXMFCM4QPPU.jpg "Microsoft executive says Google deals kept Bing small – Reuters")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/T7TOTNOOJJJGBGRNMITDKC5GIA.jpg "Epic Games is laying off about 830 employees divesting Bandcamp – Reuters")
